Alnylam Pharmaceuticals, Inc. (ALNY) Social Stream



Alnylam Pharmaceuticals, Inc. (ALNY): $132.09

4.91 (+3.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALNY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 450

in industry

Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Alnylam Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-23 19 $350 $108 $208.3 $127.18 63.78%
2021-11-19 17 $275 $108 $200 $127.18 57.26%
2021-11-22 18 $275 $108 $200 $127.18 57.26%
2021-11-22 19 $275 $108 $201.25 $127.18 58.24%
2021-12-29 19 $275 $108 $202.5 $127.18 59.22%
2021-12-29 19 $275 $108 $202.5 $127.18 59.22%
2022-01-11 19 $275 $108 $203.85 $127.18 60.28%
2022-01-18 19 $275 $108 $203.3 $127.18 59.85%

The Trend in the Analyst Price Target


Over the past 134 days, ALNY's average price target has gone up $24.51.

ALNY reports an average of 11.89% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-14 19 275 108 202.50 185.73 9.03%
2021-07-17 22 235 91 175.83 177.54 -0.96%
2021-02-13 13 235 88 172.78 157.92 9.41%
2021-11-22 19 275 108 202.50 187.01 8.28%
2021-03-06 14 235 88 174.64 143.39 21.79%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.66 11 3 5 0 0 19

The Trend in the Broker Recommendations


Over the past 153 days, ALNY's average broker recommendation rating improved by 0.64.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Alnylam Pharmaceuticals Inc's number of analysts covering the stock is higher than 656.75% of them.
  • In terms of how Alnylam Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 658.4% of that group.
  • ALNY has a lower variance in analysts' estimates than -537.23% of stocks in the large market cap category.
  • In the context of Pharmaceutical Products stocks, Alnylam Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 129.1% of them.

In the Pharmaceutical Products industry, ALKS, ABCL, and VIR are the three stocks most similar to Alnylam Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for ALNY? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6953 seconds.